Your browser doesn't support javascript.
loading
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.
Inomata, Minehiko; Tsuda, Takeshi; Ichikawa, Tomomi; Matsumoto, Masahiro; Mizushima, Isami; Azechi, Kenji; Takata, Naoki; Murayama, Nozomu; Hayashi, Kana; Hirai, Takahiro; Seto, Zenta; Tokui, Kotaro; Masaki, Yasuaki; Taka, Chihiro; Okazawa, Seisuke; Kambara, Kenta; Imanishi, Shingo; Taniguchi, Hirokazu; Miwa, Toshiro; Hayashi, Ryuji; Matsui, Shoko; Tobe, Kazuyuki.
Afiliación
  • Inomata M; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Tsuda T; Department of Respiratory Medicine, Toyama Prefectural Central Hospital, Toyama City, Japan.
  • Ichikawa T; Respiratory and Allergy Medicine, Toyama Red Cross Hospital, Toyama City, Japan.
  • Matsumoto M; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Mizushima I; Respiratory and Allergy Medicine, Toyama Red Cross Hospital, Toyama City, Japan.
  • Azechi K; Department of Respiratory Medicine, Toyama Prefectural Central Hospital, Toyama City, Japan.
  • Takata N; Department of Respiratory Medicine, Toyama Prefectural Central Hospital, Toyama City, Japan.
  • Murayama N; Respiratory and Allergy Medicine, Toyama Red Cross Hospital, Toyama City, Japan.
  • Hayashi K; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Hirai T; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Seto Z; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Tokui K; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Masaki Y; Department of Respiratory Medicine, Toyama Prefectural Central Hospital, Toyama City, Japan.
  • Taka C; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Okazawa S; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Kambara K; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Imanishi S; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Taniguchi H; Department of Respiratory Medicine, Toyama Prefectural Central Hospital, Toyama City, Japan.
  • Miwa T; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Hayashi R; Department of Medical Oncology, Toyama University Hospital, Toyama City, Japan.
  • Matsui S; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
  • Tobe K; First Department of Internal Medicine, Toyama University Hospital, Toyama City, Japan.
Thorac Cancer ; 14(17): 1618-1623, 2023 06.
Article en En | MEDLINE | ID: mdl-37101081
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Thorac Cancer Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Singapur
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Thorac Cancer Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Singapur